Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Eli Lilly's oral SERD Inluriyo crosses FDA finish line
Like the first oral SERD approved, Lilly’s imlunestrant is only cleared to treat certain breast cancers that harbor ESR1 gene mutations.
Angus Liu
Sep 25, 2025 3:35pm
Merck scores FDA approval for subcutaneous Keytruda
Sep 19, 2025 4:54pm
Boehringer's lung cancer med passes muster with the FDA
Aug 8, 2025 3:52pm
On heels of M&A deal, Jazz scores new FDA nod
Aug 6, 2025 3:26pm
Lenz's Vizz wins FDA approval to crack large presbyopia market
Aug 1, 2025 10:45am
Apellis snatches broad kidney disease expansion for Empaveli
Jul 28, 2025 8:00pm
